Literature DB >> 9210188

The effect of benzyl alcohol on recombinant human interferon-gamma.

X M Lam1, T W Patapoff, T H Nguyen.   

Abstract

PURPOSE: The goal of this study was to investigate the conformational change and aggregation of recombinant human interferon-gamma (rhIFN-gamma) as a result of interaction between benzyl alcohol and the protein. The effects of buffer concentration, buffer species, ionic strength, rhIFN-gamma and benzyl alcohol concentrations on the dynamics of the interaction in liquid formulations were also examined.
METHODS: The effect of benzyl alcohol on the secondary and tertiary structure of rhIFN-gamma in succinate and acetate buffers was studied using far-UV and near-UV circular dichroism spectrophotometry, respectively. Dynamic light scattering was employed to detect aggregate formation due to the interaction of benzyl alcohol with rhIFN-gamma.
RESULTS: The addition of benzyl alcohol at 0.9% (w/v) in various liquid rhIFN-gamma formulations induced changes in circular dichroism (CD) spectra of the protein in the near-UV region, while the CD spectra in the far-UV region remained unaltered. There were gradual decreases in ellipticity with time throughout the near-UV CD spectra. The decreases in near-UV ellipticity induced by benzyl alcohol were accompanied by the formation of high molecular weight aggregates as measured by dynamic light scattering. Loss in near-UV ellipticity was accelerated at lower protein concentration and by increasing buffer or benzyl alcohol concentration. It was also faster in succinate than in acetate buffer. Formulation ionic strength did not affect the CD spectral changes in both the near- and far-UV regions.
CONCLUSIONS: Interaction between benzyl alcohol and rhIFN-gamma is formulation dependent. Protein concentration, buffer species, buffer concentration, and preservative concentration play a significant role in determining the extent of the interaction and consequently the stability of the product.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9210188     DOI: 10.1023/a:1012190120061

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  Acid unfolding and self-association of recombinant Escherichia coli derived human interferon gamma.

Authors:  T Arakawa; Y R Hsu; D A Yphantis
Journal:  Biochemistry       Date:  1987-08-25       Impact factor: 3.162

2.  pH dependence of the reversible and irreversible thermal denaturation of gamma interferons.

Authors:  M G Mulkerrin; R Wetzel
Journal:  Biochemistry       Date:  1989-08-08       Impact factor: 3.162

3.  PPD-stimulated interferon: in vitro macrophage-lymphocyte interaction in the production of a mediator of cellular immunity.

Authors:  L B Epstein; M J Cline; T C Merigan
Journal:  Cell Immunol       Date:  1971-12       Impact factor: 4.868

4.  Parenteral toxicity studies with benzyl alcohol.

Authors:  E T Kimura; T D Darby; R A Krause; H D Brondyk
Journal:  Toxicol Appl Pharmacol       Date:  1971-01       Impact factor: 4.219

5.  In-process protein degradation by exposure to trace amounts of sanitizing agents.

Authors:  L E Kirsch; R M Riggin; D A Gearhart; D S Lefeber; D L Lytle
Journal:  J Parenter Sci Technol       Date:  1993 Jul-Aug

6.  Natural human interferon-gamma. Complete amino acid sequence and determination of sites of glycosylation.

Authors:  E Rinderknecht; B H O'Connor; H Rodriguez
Journal:  J Biol Chem       Date:  1984-06-10       Impact factor: 5.157

7.  Interferon-Like Virus-Inhibitor Induced in Human Leukocytes by Phytohemagglutinin.

Authors:  E F Wheelock
Journal:  Science       Date:  1965-07-16       Impact factor: 47.728

8.  Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma.

Authors:  R A Ezekowitz; M C Dinauer; H S Jaffe; S H Orkin; P E Newburger
Journal:  N Engl J Med       Date:  1988-07-21       Impact factor: 91.245

9.  Recombinant human interferon-gamma reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood.

Authors:  J M Sechler; H L Malech; C J White; J I Gallin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

10.  Structural studies on acid unfolding and refolding of recombinant human interferon gamma.

Authors:  Y R Hsu; T Arakawa
Journal:  Biochemistry       Date:  1985-12-31       Impact factor: 3.162

View more
  13 in total

1.  Liposomes as formulation excipients for protein pharmaceuticals: a model protein study.

Authors:  S V Balasubramanian; J Bruenn; R M Straubinger
Journal:  Pharm Res       Date:  2000-03       Impact factor: 4.200

Review 2.  Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation.

Authors:  Eva Y Chi; Sampathkumar Krishnan; Theodore W Randolph; John F Carpenter
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

3.  Scientific considerations for generic synthetic salmon calcitonin nasal spray products.

Authors:  Sau L Lee; Lawrence X Yu; Bing Cai; Gibbes R Johnsons; Amy S Rosenberg; Barry W Cherney; Wei Guo; Andre S Raw
Journal:  AAPS J       Date:  2010-10-30       Impact factor: 4.009

Review 4.  Protein particulate detection issues in biotherapeutics development--current status.

Authors:  Tapan K Das
Journal:  AAPS PharmSciTech       Date:  2012-05-08       Impact factor: 3.246

5.  Interactions Between Peptide and Preservatives: Effects on Peptide Self-Interactions and Antimicrobial Efficiency In Aqueous Multi-Dose Formulations.

Authors:  P Heljo; A Ross; I E Zarraga; A Pappenberger; H-C Mahler
Journal:  Pharm Res       Date:  2015-04-18       Impact factor: 4.200

6.  Role of partial protein unfolding in alcohol-induced protein aggregation.

Authors:  Surinder M Singh; Javier Cabello-Villegas; Regina L Hutchings; Krishna M G Mallela
Journal:  Proteins       Date:  2010-09

7.  Non-native intermediate conformational states of human growth hormone in the presence of organic solvents.

Authors:  Muppalla Sukumar; Sacha M Storms; Michael R De Felippis
Journal:  Pharm Res       Date:  2005-05-17       Impact factor: 4.200

8.  Mechanisms of m-cresol-induced protein aggregation studied using a model protein cytochrome c.

Authors:  Surinder M Singh; Regina L Hutchings; Krishna M G Mallela
Journal:  J Pharm Sci       Date:  2011-01-12       Impact factor: 3.534

9.  Effect of benzyl alcohol on recombinant human interleukin-1 receptor antagonist structure and hydrogen-deuterium exchange.

Authors:  John R Alford; Andrew C Fowler; Deborah S Wuttke; Bruce A Kerwin; Ramil F Latypov; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2011-05-05       Impact factor: 3.534

10.  Development of a multidose formulation for a humanized monoclonal antibody using experimental design techniques.

Authors:  Supriya Gupta; Elizabet Kaisheva
Journal:  AAPS PharmSci       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.